Patents by Inventor Chi-Hsin King

Chi-Hsin King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYAMINE COMPOUNDS
    Publication number: 20080058382
    Abstract: This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Application
    Filed: August 6, 2007
    Publication date: March 6, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Chi-Hsin King, Hua-Chien Chen, Gholam Hakimelahi, Shu-Jen Chen, Ying-Huey Huang, Chien-Huang Wu
  • Pyrimidine compounds
    Publication number: 20060293324
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
    Type: Application
    Filed: June 13, 2006
    Publication date: December 28, 2006
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Ming-Chen Chou, Chen-Tso Tseng, Chien-Huang Wu, Ying-Huey Huang, Shu-Jen Chen, Chi-Hsin King
  • Pyrimidine compounds
    Publication number: 20060281712
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
    Type: Application
    Filed: June 13, 2006
    Publication date: December 14, 2006
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Ming-Chen Chou, Chen-Tso Tseng, Chien-Huang Wu, Ying-Huey Huang, Shu-Jen Chen, Chi-Hsin King
  • Novel compounds as pharmaceutical agents
    Publication number: 20060058295
    Abstract: The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
    Type: Application
    Filed: November 24, 2003
    Publication date: March 16, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Timothy Burkholder, Todd Decollo, Alexander Godfrey, Charles Heap, Chi-Hsin King, Hong-Yu Li, William McMillen, Jason Sawyer, Yan Wang, Clive Diefenbacher, Thomas Engler, Sushant Malhotra, Sreenivasa Mundla
  • Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
    Publication number: 20050261341
    Abstract: The present invention provides various processes for the preparation of (R)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol.
    Type: Application
    Filed: April 26, 2005
    Publication date: November 24, 2005
    Applicants: Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland GmbH
    Inventors: Wolfgang Laux, Gerard Guillamot, Frederick Laskovics, Chi-Hsin King, James Hitt, Sandra Stolz-Dunn, Ian Tomlinson, Johannes Koek